Obulytix
Obulytix develops enzyme-based antibiotics to combat antimicrobial resistance. It engineers Precision Lysin Therapeutics (PLTs), targeted proteins that kill specific bacteria rapidly. The company operates as a biotechnology research firm focused on next-generation antibiotics. Core tech includes protein engineering, enzyme-based mechanisms, and biologics delivery for clinical settings. Its market focus is B2B collaborations with hospitals, research centers, and pharma partners to scale impact.
Obulytix
Obulytix develops enzyme-based antibiotics to combat antimicrobial resistance. It engineers Precision Lysin Therapeutics (PLTs), targeted proteins that kill specific bacteria rapidly. The company operates as a biotechnology research firm focused on next-generation antibiotics. Core tech includes protein engineering, enzyme-based mechanisms, and biologics delivery for clinical settings. Its market focus is B2B collaborations with hospitals, research centers, and pharma partners to scale impact.